Extraperitoneal SINgle-port rObotic-assisted Radical Prostatectomy (RARP) Versus Transperitoneal Multi-port RARP in the Treatment Of Prostate Cancer (SINO-TOP)

NARecruitingINTERVENTIONAL
Enrollment

480

Participants

Timeline

Start Date

January 8, 2024

Primary Completion Date

June 30, 2025

Study Completion Date

December 31, 2025

Conditions
Prostate AdenocarcinomaLocalized Prostate Carcinoma
Interventions
PROCEDURE

Single-port extraperitoneal robotic-assisted radical prostatectomy with Vattikuti Institute Prostatectomy(VIP) techniques

Patients with localized prostate cancer are randomized into this group in a 1:1 ratio and receive single-port extraperitoneal robotic-assisted radical prostatectomy with Vattikuti Institute Prostatectomy(VIP) techniques. The investigators will monitor patients for perioperative data recording, treatment and 1-year follow-up.

PROCEDURE

Multi-port transperitoneal robotic-assisted radical prostatectomy with bilateral intrafascial nerve-sparing techniques

Patients with localized prostate cancer are randomized into this group in a 1:1 ratio and receive multi-port transperitoneal robotic-assisted radical prostatectomy with bilateral intrafascial nerve-sparing techniques. The investigators will monitor patients for perioperative data recording, treatment and 1-year follow-up.

Trial Locations (1)

201109

RECRUITING

Changzheng hospital, Shanghai

All Listed Sponsors
collaborator

Shanghai Zhongshan Hospital

OTHER

collaborator

ShuGuang Hospital

OTHER

collaborator

The Third Affiliated Hospital of Naval Medical University

UNKNOWN

collaborator

The First Affiliated Hospital of Guangzhou Medical University

OTHER

collaborator

Sir Run Run Shaw Hospital

OTHER

collaborator

Sichuan Provincial People's Hospital

OTHER

lead

Shanghai Changzheng Hospital

OTHER